Cardionovum

Be up
to date.

Latest press release

Dr. Berghmans and Dr. van Bouckenooghe were the worldwide first users of the LEGFLOW 018 on a Patient with CLI disease. The product was used in BtK and showed excellent performance. In addition the patient received a DCB therapy with our LEGFLOW OTW in the SFA as well.

CARDIONOVUM GmbH today announced the completion of enrollment of the RAPID trial. Results will be used to further support the safety and effectiveness of CARDIONOVUM’s Legflow® drug-coated balloon (DCB).

CARDIONOVUM GmbH, a medical technology company developing and commercializing innovative medical devices such as drug-coated balloons and drug-eluting stents for the treatment of coronary and peripheral artery disease, announced today the enrollment of the first patient in the MAGNIFICENT trial.

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Upcoming events

Cardionovum® at CIRSE 2024

Cardionovum® is glad to inform that will attend CIRSE 2024.

Location:

CCL – Lisbon Congress Centre
Praça das Industrias 1
1300-307 Lisbon
Portugal

Date: Sep 14, 2024–Sep 18, 2024

Latest events

Cardionovum at Charing Cross

Cardionovum participates at Charing Cross

Date: Apr 25, 2016–Apr 28, 2016

Location: London, UK

Visit website >>

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 25, 2016–Jan 28, 2016

Location: Leipzig, Germany

Learn more >>

Visit website >>

go top